Pilot trial to evaluate the efficacy and tolerance of a simple once daily combined regimen including tenofovir (TDF), emtricitabine (FTC) and efavirenz (EFZ) [efavirenz/emtricitabine/tenofovir disoproxil fumarate] in HIV-1 infected patients naive to prior antiretroviral treatment in Senegal

Trial Profile

Pilot trial to evaluate the efficacy and tolerance of a simple once daily combined regimen including tenofovir (TDF), emtricitabine (FTC) and efavirenz (EFZ) [efavirenz/emtricitabine/tenofovir disoproxil fumarate] in HIV-1 infected patients naive to prior antiretroviral treatment in Senegal

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jul 2007

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top